Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

Items 1-10 of 64

Page
per page
  1. GSK 2837808A
    B4929 GSK 2837808A
    Target: Lactate Dehydrogenases (LDH)
    Summary: Potent, selective lactate dehydrogenase A (LDHA) inhibitor
      ≥9.12 mg/mL
  2. Ferrostatin-1 (Fer-1)
    A4371 Ferrostatin-1 (Fer-1)
    Target: Ferroptosis
    Summary: Ferroptosis inhibitor, erastin-induced
      ≥149 mg/mL
  3. Alda 1
    B5508 Alda 1
    Target: Aldehyde Dehydrogenases
    Summary: ALDH2 activator
      insoluble in H2O; ≥15.15 mg/mL
  4. GSK3787
    A4303 GSK3787
    Summary: PPARβ/δ antagonist,novel and irreversible
      insoluble in H2O; ≥15.8 mg/mL
  5. INCB024360 analogue
    A3493 INCB024360 analogue
    Summary: potent and selective inhibitor of IDO1
      ≥13.55 mg/mL
  6. A922500
    A4382 A922500
    Target: DGAT
    Summary: DGAT-1 inhibitor
      ≥21.25 mg/mL
  7. Cilostazol
    A4337 Cilostazol
    Summary: PDE3 inhibitor
      insoluble in H2O; ≥15.4 mg/mL
  8. CBR-5884
    A8721 CBR-5884
     1 Citation
    Target: 3-phosphoglycerate dehydrogenase
    Summary: selective inhibitor of PHGDH
      insoluble in EtOH; insoluble in H2O; ≥16.8 mg/mL
  9. AN-2728
    A3178 AN-2728
    Summary: PDE4 inhibitor,anti-inflammatory compound
      insoluble in H2O; ≥12.55 mg/mL
  10. Tosedostat (CHR2797)
    A4355 Tosedostat (CHR2797)
     1 Citation
    Target: Aminopeptidases
    Summary: Aminopeptidase inhibitor
      ≥40.6 mg/mL

Items 1-10 of 64

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. PPAR 1 item
  2. Aminopeptidase 1 item
  3. Carbonic Anhydrase 3item
  4. CETP 2item
  5. CYP3A/CYP450 1 item
  6. Dehydrogenase 5item
  7. DGAT 1 item
  8. Dopamine β-hydroxylase 2item
  9. FAAH 1 item
  10. Factor Xa 1 item
  11. Ferroptosis 1 item
  12. HMG-CoA Reductase 5item
  13. HSP 9item
  14. IDO 3item
  15. KRAS-PDEδ 1 item
  16. Lipid Metabolism 1 item
  17. P450 3item
  18. PDE 12item
  19. Phospholipase 2item
  20. SCD 1 item
  21. SGLT 1 item
  22. Transferase 6item
  23. monooxygenase 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 10item
  4. 3-phosphoglycerate dehydrogenase 1 item
  5. Kynurenine-3-monooxygenase 1 item
  6. Aminopeptidases 1 item
  7. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  8. HSP90 7item
  9. Cytochrome P450 (CYP450) 3item
  10. Ferroptosis 1 item
  11. HMG-CoA Reductases 5item
  12. SGLT 1 item
  13. DGAT 2item
  14. CETP 2item
  15. Lactate Dehydrogenases (LDH) 2item
  16. Fatty-acid-binding proteins (FABPs) 1 item
  17. IDH2 1 item
  18. Nampt 1 item
  19. Carbonic Anhydrases 3item
  20. Aldehyde Dehydrogenases 2item
  21. Phospholipases 1 item
  22. Catechol O-Methyltransferase (COMT) 1 item
  23. FPTase 1 item
  24. Ftase 1 item
  25. FAAH 1 item
  26. IDO 1 item
  27. Glycogen Phosphorylases 1 item
Reported Experiments
  1. Animal Experiments 60item
  2. Cell Experiments 44item
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 2item
  4. Bladder Carcinoma 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 8item
  7. Cancer 25item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Cocaine-Related Disorders 2item
  10. Colon Cancer 1 item
  11. Diabetes 2item
  12. Dyslipidemia 1 item
  13. Epilepsy 1 item
  14. Erectile Dysfunction 3item
  15. Glioblastoma 1 item
  16. Glioma 1 item
  17. Hepatic Cancer 1 item
  18. HIV Infections 1 item
  19. Hypercholesterolemia 2item
  20. Inflammation 1 item
  21. Inflammatory Diseases 1 item
  22. Leukemia 1 item
  23. Lung Cancer 3item
  24. Lymphoma 1 item
  25. Melanoma 7item
  26. Multiple Myeloma 2item
  27. Neuroblastoma 2item
  28. Neurocognitive Disorders 1 item
  29. Non-small Cell Lung Cancer 2item
  30. Obsessive-Compulsive Disorder 1 item
  31. Osteoporosis 1 item
  32. Pancreatic Cancer 2item
  33. Pancreatic Carcinoma 1 item
  34. Prostate Cancer 7item
  35. Psoriasis 2item
  36. Psoriasis Vulgaris 1 item
  37. Pulmonary Arterial Hypertension 1 item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 2item
  40. Type 2 Diabetes 2item